When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis
Authors:
- 1 July 2009
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 68 (7) , 1228-1229
Abstract
This study is embedded in the Arthritis and Biologicals in Children (ABC) project, a prospective ongoing multicentre, observational study that includes all Dutch patients with JIA who used etanercept since 1999.2 3 We selected all patients who discontinued etanercept because of sustained good clinical response determined by the treating doctor. The outcome measures to assess disease activity consisted of the JIA core set of …Keywords
This publication has 5 references indexed in Scilit:
- Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national registerAnnals of the Rheumatic Diseases, 2009
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trialThe Lancet, 2008
- Development of a web-based register for the Dutch national study on biologicals in JIA: www.ABC-register.nlRheumatology, 2008
- Measuring clinical response and remission in juvenile idiopathic arthritisCurrent Opinion in Rheumatology, 2007
- Preliminary definition of improvement in juvenile arthritisArthritis & Rheumatism, 1997